Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
| Image |  |
|---|---|
| Description | scientific article published on January 2007 |
| Author/s |
author: Carmen Burgaleta Dunia de Miguel |
| Publication date | January 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |